RALLYBIO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 USD | -0.67% |
|
-11.38% | -38.08% |
| 05-15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
| 05-09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RALLYBIO CORPORATION | Other Biotechnology & Medical Research | -0.67% | -11.38% | -38.08% | -81.10% | - | 61.34M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RLYB Stock
- Charts Rallybio Corporation
- Comparison Chart
